Article Information
History
- October 30, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Kevin C. Ma1,
- Jaime E. Hale2,
- Yonatan H. Grad1,
- Galit Alter3,
- Katherine Luzuriaga4,5,
- Roger B. Eaton2,6,
- Stephanie Fischinger3,
- Devinder Kaur2,6,
- Robin Brody4,
- Sameed M. Siddiqui7,8,
- Dylan Leach9,
- Catherine M. Brown9,
- R. Monina Klevens9,
- Lawrence Madoff9,* and
- Anne Marie Comeau2,6,*
- 1Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA
- 2New England Newborn Screening Program, UMass Chan Medical School, Worcester, Massachusetts, USA
- 3Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, Massachusetts, United States
- 4Program in Molecular Medicine, T.H. Chan School of Medicine at UMass Chan Medical School, Worcester, Massachusetts, USA
- 5UMass Center for Clinical and Translational Science at UMass Chan Medical School, Worcester, Massachusetts, USA
- 6Department of Pediatrics, T.H. Chan School of Medicine at UMass Chan Medical School, Worcester, Massachusetts, USA
- 7Computational and Systems Biology Program, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA
- 8Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA
- 9Bureau of Infectious Disease and Laboratory Sciences, Massachusetts Department of Public Health, Boston, Massachusetts, USA
- ↵*Correspondence: Anne Marie Comeau (Anne.Comeau{at}umassmed.edu) or Lawrence Madoff (larry.madoff{at}state.ma.us).
Authors KCM and JEH contributed equally to this manuscript. Authors LM and AMC contributed equally to this manuscript.
Posted October 30, 2021.
Trends in SARS-CoV-2 seroprevalence in Massachusetts estimated from newborn screening specimens
